In both colon cancer cell lines, treatment with the anti-neoplastic drugs decreased significantly methylation of the CAV1 promoter region (Figure 4), which likely explains, at least in part, the increase in CAV1 mRNA (Figure 3) and protein (Figure 2) levels observed following drug exposure. The gene discussed is CAV1; the disease is colonic neoplasm.